✅ DDx: Abdominal Pain / Diarrhea / GI Bleed Flashcards
Blunt abdominal trauma (BAT)
After primary survey, patients with BAT should be assessed for the presence of intra-abdominal organ injury with a bedside Focused Assessment with Sonography for Trauma (FAST), which evaluates both the abdomen and pericardium. Hemodynamically unstable patients with positive FAST (eg, intraperitoneal fluid) should be taken for exploratory laparotomy.
Cx:
Hepatic laceration (HL), one of the most common solid organ injuries, along with splenic lacerations, due to BAT. Other manifestations of HL include right upper quadrant pain and right shoulder pain due to irritation of the phrenic nerve from hemorrhage. Factors increasing the likelihood of intra-abdominal injury include the “seat belt sign” (ecchymosis over the abdomen in the pattern of a seat belt), rebound tenderness, abdominal distension/guarding, and concomitant femur fracture.
Urethral injury (eg, blood at the urethral meatus, high-riding prostate).
Anterior urethral injury: penile trauma (eg, laceration, contusion) is often visible.
Bulbomembranous junction (junction of the anterior and posterior urethra) is the most common site of urethral injury.
Posterior urethral injury (eg, membranous urethral injury) and bulbomembranous transection, digital rectal examination may reveal a high-riding prostate.
Extraperitoneal bladder injury (EPBI) may consist of either contusion or rupture of the neck, anterior wall, or anterolateral wall of the bladder. In the case of rupture, extravasation of urine into adjacent tissues causes localized pain in the lower abdomen and pelvis. Pelvic fracture is almost always present in EPBI, and sometimes a bony fragment can directly puncture and rupture the bladder. Gross hematuria is also usually present, and urinary retention (evidenced by suprapubic fullness in this patient) may occur, especially in the case of injury to the bladder neck.
Anterior bladder wall and the bladder neck are extraperitoneal structures. A tear in these locations is almost always accompanied by pelvic fracture and causes extraperitoneal leakage of urine, leading to localized lower abdominal pain.
Dome of bladder
Spillage of blood, bowel contents, bile, pancreatic secretions, or urine into the peritoneal cavity can cause acute chemical peritonitis ❗, which is evidenced by diffuse abdominal pain and guarding. The superior and lateral surfaces of the bladder compose the dome of the bladder and are bordered by the peritoneal cavity. Therefore, rupture of the dome of the bladder causes urine to spill into the peritoneum, leading to peritonitis. Bladder rupture after blunt trauma is due to a sudden increase in intravesical pressure and most likely occurs following a blow to the lower abdomen when the bladder is full and distended.
In addition, irritation of the peritoneal lining of the right or left hemidiaphragm may cause referred pain to the ipsilateral shoulder (Kehr sign) as sensory innervation to the shoulder originates from the C3 to C5 spinal roots; these roots are also the origin of the phrenic nerve innervating the diaphragm.
Penetrating abdominal trauma (PAT)
Following completion of the primary survey, the evaluation of patients with PAT should focus on identifying potentially life-threatening indications for urgent exploratory laparotomy to prevent sepsis or exsanguinating hemorrhage.
The presence of any of the following suggests significant injury and is an indication for urgent exploratory laparotomy:
- Hemodynamic instability
- Peritonitis (rebound tenderness, guarding)
- Evisceration (ie, externally exposed intestines)
- Blood from a nasogastric tube or on rectal examination
Patients without indications for urgent laparotomy should undergo further evaluation, including local exploration of the wound and an extended ultrasound examination (eg, extended Focused Assessment with Sonography for Trauma [eFAST], which evaluates for pneumothorax and hemothorax in addition to intraperitoneal injuries).
Nausea (Antiemetics)
Ondansetron (Zofran): Serotonin (5HT) receptor antagonists (eg, ondansetron) that target the 5HT3 receptor are considered first-line treatment for chemotherapy-induced nausea. They have a low side-effect profile and are highly efficacious. These medications can be used to manage acute emesis but are also useful as prophylaxis, sometimes in combination with corticosteroids.
Metoclopromide (Regalin)
Promethazine (Phenergen) [Rectal]
Lorazepam (Ativan)
Scopolamine
Haldol
Bowel Regimen
Senna (stimulant laxative)
Miralax
Regalin
Feeding Tube
Dobhoff
Abdominal Pain: General
The first priority when evaluating abdominal pain is to determine whether the pain is acute or chronic. Sudden and/or severe onset of pain should lead the clinician toward an emergent evaluation.
Inflammatory Bowel Disease (Chron’s, Ulcerative Colitis)
Ulcerative colitis
Clinical features
- <4 watery bowel movements per day
- Hematochezia is rare or intermittent
Laboratory findings
- No anemia
- Elevated ESR & CRP (may be normal in mild disease)
Treatment
- 5-Aminosalicylic acid agents (eg, mesalamine, sulfasalazine)
Mild UC is defined as <4 watery bowel movements a day with intermittent hematochezia, normal inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate), and no anemia. Dx: Colonoscopy is needed to confirm the diagnosis and usually shows inflammation and superficial ulcerations extending from the anorectum continuously to more proximal regions of the colon.
Both CD and UC present with chronic diarrhea, abdominal pain, anemia, and elevated inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate).
Dx: Diagnosing IBD and distinguishing between CD and UC requires colonoscopy with biopsies. Based on the increased cancer risk, routine surveillance colonoscopy with biopsies every 1 to 2 years is warranted beginning 8 to 10 years after diagnosis.
Ulcerative colitis
- Inflammation is limited to the mucosa and submucosa
- Colonic mucosal inflammation and 👾crypt abscesses
- Rectum and Colon
- Continuous lesions
- Bloody diarrhea
Crohn disease
- Can affect the entire GI tract from mouth to anus
- Full thickness involvement of the gut wall, can lead to fistulas and deep abscesses.
- Noncaseating Granuloma formation on biopsies
- Cobblestoning, creeping fat
- Perianal disease with rectal sparing
Extraintestinal Manifestations:
Ankylosing spondylitis: Rare complication; seen more in CD than UC.
Aphthous stomatitis: Small ulcers between gums and lower lip or along tongue; related to disease activity.
Enteropathic arthritis (arthritic conditions associated with gastrointestinal disease)
Peripheral arthritis: Frequently classified as one of two types: type 1 affects large joints of arms and legs (elbows, wrists, knees, ankles); symptoms often acute and migratory; correlate with active bowel disease. Type 2 is symmetric, affects small joints, and is often chronic; unrelated to bowel disease activity.
Primary sclerosing cholangitis: Severe inflammation and scarring of bile ducts; more common in UC and men. Hx: Jaundice, nausea, pruritus, weight loss. May be complicated by cholangiocarcinoma or colon cancer.
Sacroiliitis: Pain and stiffness in lower spine and sacroiliac joints; may present before IBD symptoms.
Scleritis: Deep pain, redness of sclera. An ophthalmologic emergency.
Uveitis: Pain, blurry vision, photosensitivity, redness of eye. An ophthalmologic emergency (UC)
Osteoporosis: More common in women with CD. Periodic screening important.
Erythema nodosum: Tender, red nodules over 🦵shins and ankles; more common in UC and women; related to IBD disease activity.
Pyoderma gangrenosum: Papules and pustules coalesce to form deep, chronic ulcers, often on shins and ankles; more common in UC; related to IBD disease activity.
Tx:
5-Aminosalicylates
Sulfasalazine, olsalazine, balsalazide, mesalamine: oral, rectal
Initial management for mild UC is with 5-aminosalicylic acid (5-ASA) medications (eg, mesalamine, sulfasalazine, balsalazide), which are used for both induction and maintenance therapy. Mesalamine enemas or suppositories are preferred in patients with UC confined to the rectosigmoid, whereas oral 5-ASA medications are needed for more extensive disease.
Antibiotics (metronidazole, ciprofloxacin)
Glucocorticoids
Oral, intravenous, rectal
Budesonide
Immunomodulators
Methotrexate
Cyclosporine
6-MP, azathioprine
Biological Agents
Anti–TNF-α (adalimumab, certolizumab pegol, infliximab)
Natalizumab
Cx: Crohns
Strictures are a complication of Crohn disease that result from poorly controlled, severe inflammation. Smoking and young age (<30) at diagnosis are significant risk factors for uncontrolled inflammation and disease progression despite medical therapy.
SBO due to fibrotic stricture typically presents with bilious vomiting, severe abdominal pain, and either partial (ie, ability to pass gas but not stool) or complete (ie, inability to pass flatus or stool) obstruction. Abdominal examination commonly reveals distension and high-pitched (tympanic) bowel sounds.
Although medical treatment for Crohn disease (eg, infliximab) can reduce inflammation and may help prevent fibrotic stricture development it cannot resolve a stricture once one develops. Depending on the location and length of the stricture, surgical resection may be required.
[IBS] Irrirable Bowel SyndROME
Functional disorder of the gastrointestinal tract (with no identifiable organic cause). It is the most common gastrointestinal diagnosis in North America, with a prevalence of 10%-15%.
IBS is further subclassified as diarrhea-predominant, constipation-predominant, or mixed.
Hx: IBS presents most commonly in young women as chronic, crampy abdominal pain with alternating episodes of constipation and diarrhea. Passage of stool often relieves the pain.
Dx: Patients meeting the Rome III (IBS) diagnostic criteria have recurrent abdominal pain or discomfort at least 3 days each month in the past 3 months (12 weeks) (with onset more than 6 months earlier) [not necessarily consecutive] associated with two or more of the following:
- Improvement with defecation;
- Onset associated with change in frequency of stool;
- Onset associated with change in form (appearance) of stool.
Dx: Further testing is not required unless alarm features are present that suggest an alternate diagnosis.
Normal colonoscopy
Alarm symptoms (not present) include onset after age 50 years, brief history of symptoms, weight loss, nocturnal symptoms, family history of colon cancer, rectal bleeding, and recent antibiotic use.
- Older age of onset (≥50)
- Gastrointestinal bleeding
- Nocturnal diarrhea
- Worsening pain
- Unintended weight loss
- Iron deficiency anemia
- Elevated C-reactive protein
- Positive fecal lactoferrin or calprotectin
- Family history of early colon cancer or IBD
Tx: FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols)diet
Celiac disease
In children:
Risk factors
- First-degree relative with celiac disease
- Autoimmune disorders
- Down syndrome
Clinical features
- Abdominal pain, bloating, diarrhea
- Failure to thrive, short stature
- Dermatitis herpetiformis, a pruritic papular or vesicular rash 🌹 associated with celiac disease, is located on the knees, elbows, forearms, and buttocks.
Workup
- ↑ Tissue transglutaminase IgA antibody
- Intestinal biopsy (villous atrophy)
Treatment
- Gluten-free diet
Celiac disease occurs in genetically predisposed persons with haplotype HLA-DQ2 or HLA-DQ8
Hx: Abdominal pain, bloating, diarrhea triggered by ingestion of gluten that is present in wheat, rye, and barley. Malabsorption (weight loss, postprandial bloating, and bulky, foul-smelling stools that float), malnutruition, and iron deficiency anemia may be present.
- Fat and protein: loss of muscle mass, loss of subcutaenous fat, fatigue
- Iron: Pallor, fatigue
- Calcium and Vitamin D: Bone pain (osteomalacia), fracture (osteoporosis)
- Vitamin K: Easy brusing
- Vitamin A: Hyperkeratosis
Dx:
IgA anti-tissue transglutaminase and IgA anti-endomysial antibodies.
❗ Many patients with biopsy-confirmed celiac disease will have negative results on IgA antibody testing due to an associated selective IgA deficiency, which is common in celiac disease. If IgA serology is negative but the suspicion for celiac disease is high, total IgA should be measured (or IgG-based serologic testing should be done).
🌈 D-xylose is a monosaccharide that can be absorbed in the proximal small intestine without degradation by pancreatic or brush border enzymes. It is subsequently excreted in the urine. In the D-xylose test, the patient is given an oral dose of D-xylose, with subsequent assay of urine and venous blood. Patients with proximal small intestinal mucosal disease (eg, celiac disease) cannot absorb the D-xylose in the intestine, and urinary and venous D-xylose levels will be low. By contrast, patients with malabsorption due to enzyme deficiencies (eg, chronic pancreatitis) will have normal absorption of D-xylose
Tx: Avoidance of gluten-containing foods is curative
🚧 SBO
High-pitched bowel sounds on examination. In association with the abdominal x-rays demonstrating distended loops of bowel with air-fluid levels.
Hx: Nausea, vomiting, and distension; colicky pain
Dx: Obstructive pattern seen on CT or abdominal series
Px: Hyperactive bowel sounds
SBO is further categorized by anatomic location (ie, proximal versus mid/distal) or simple versus strangulated.
Complete proximal obstructions are characterized by early vomiting, abdominal discomfort, and abnormal contrast filling on x-ray.
Mid or distal obstructions typically present as colicky abdominal pain, delayed vomiting, prominent abdominal distension, constipation-obstipation, hyperactive bowel sounds, and dilated loops of bowel on abdominal x-ray.
Simple obstruction refers to luminal occlusion; strangulation refers to loss of blood supply to the bowel wall. Patients with strangulated obstructions may have peritoneal signs (eg, rigidity, rebound) and signs of shock; fever, tachycardia, and leukocytosis are late findings.
Adhesions are by far the most common cause of SBO. They may be congenital in children (eg, Ladd’s bands), but typically result from abdominal operations or inflammatory processes. This adult patient with an SBO is likely to have had abdominal surgery, such as an appendectomy.
Paralytic (adynamic) ileus
Ileus is most commonly a complication of abdominal surgery but can also be seen in other conditions such as retroperitoneal/abdominal hemorrhage, intraabdominal inflammation (eg, pancreatitis), intestinal ischemia, and electrolyte abnormalities. Contributors to the pathophysiology of ileus include irritation and temporary paralysis of the abdominal sympathetic and parasympathetic nervous system, local release of inflammatory mediators, and opioid analgesic use.
Signs and symptoms of ileus include nausea, vomiting, abdominal distension, failure to pass flatus or stool (obstipation), and hypoactive or absent bowel sounds. The diagnosis is clinical, but abdominal x-rays (classically revealing uniformly dilated, gas-filled loops of bowel with no transition point) can be helpful in confirmation.
Management is conservative and includes bowel rest, supportive care, and treatment of secondary causes.
Postoperative ileus
Delayed return of bowel function >72 hours after surgery. Risk factors include surgical complications (eg, ureteral injury), bowel manipulation (eg, laparotomy), and longer surgery duration due to increased intraabdominal inflammation and elevated sympathetic nervous system tone. Patients with postoperative ileus have temporary bowel paralysis (ie, no forward peristalsis), causing backup of gastric secretions and gas that results in abdominal distension and vomiting (eg, hypokalemia, dehydration [elevated creatinine]). Other signs include decreased bowel sounds and absent flatus.
Diagnosis is primarily clinical, although imaging can help differentiate ileus from small bowel obstruction (SBO). Abdominal x-rays in patients with ileus typically reveal uniformly dilated bowel loops due to generalized bowel paralysis throughout both small and large bowel.
In contrast, patients with SBO have a discrete transition point (ie, the obstruction) that results in dilated small bowel proximal to the obstruction and decompressed large bowel (ie, absent rectal gas) distally.
Postoperative ileus typically self-resolves as bowel motility gradually returns; therefore, patients are conservatively managed with antiemetics, bowel rest, and serial examinations. Opiates, which further decrease bowel motility, should be avoided if possible.
Gallstone ileus
Occurs when a gallstone passes through a biliary-enteric fistula into the small bowel. As the stone advances it may cause intermittent “tumbling” obstruction with diffuse abdominal pain and vomiting until finally lodging in the ileum, the narrowest section of the bowels, several days later.
In addition to experiencing colicky pain and vomiting, patients may report distension and inability to pass flatus or stool and show signs of hypovolemia (eg, hypotension, tachycardia). Stones can occasionally also lodge in the stomach, jejunum, or colon. Cholecystitis, which predisposes to biliary-enteric adhesions, is the most important risk factor, and patients are more commonly elderly women, which reflects their higher prevalence of gallstone disease.
Diagnosis can be confirmed by abdominal CT scan, which may reveal gallbladder wall thickening, pneumobilia, and an obstructing stone. Treatment is surgical and involves removal of the stone and either simultaneous or delayed cholecystectomy.
Groin hernias
Groin hernias (ie, inguinal, femoral) result from protrusion of intraabdominal (eg, small bowel) or pelvic contents through the abdominal wall.
Uncomplicated hernias typically present as a groin bulge that becomes more prominent with increased intraabdominal pressure (eg, cough, Valsalva).
Femoral Hernia - A displacement of abdominal or pelvic contents through a widened or laxed femoral ring (medial to the femoral artery and lateral to the inguinal ligament).
Risk factors include chronic cough (eg, chronic obstructive pulmonary disease), constipation, and smoking. Most cases arise in older women and present as a nonpulsatile mass in the groin. The mass generally worsens with increased abdominal pressure (eg, standing, Valsalva maneuver, coughing) and improves with decreased abdominal pressure (eg, lying down). When a bowel loop is present within the hernia, it is often tympanitic to percussion.
Because femoral hernias pass through a narrow orifice, they are associated with a substantial risk of incarceration (trapping of abdominal/pelvic contents within the hernia) and strangulation (constriction of blood flow with subsequent ischemia/necrosis).
Therefore, asymptomatic femoral hernias are generally referred for elective surgical repair to prevent potentially life-threatening complications and subsequent high-risk emergency surgery, which is associated with an increased risk of morbidity (eg, bowel resection) and mortality.
Inguinal hernias (hernia above the inguinal ligament) are associated with a lower risk for incarceration and strangulation because hernia contents pass through a wider orifice. Therefore, most asymptomatic inguinal hernias can be managed with reassurance and watchful waiting. Observation can also be considered for patients with chronic (>3 months), stable femoral hernias, but is not recommended for most patients with femoral hernias due to the risk of incarceration.
Cx: Incarceration occurs when hernia contents become trapped within the hernia sac, which can result in SBO; reduced venous outflow eventually leads to ischemia and necrosis (strangulation).
Differential Diagnosis: Midepigastric or Periumbilical:
Acute pancreatitis
Inferior myocardial infarction
Perforating peptic ulcer
Mesenteric ischemia
Small bowel obstruction
Aortic dissection or rupture
Diabetic ketoacidosis
Celiac disease
Others (LUQ): PUD, perforated ulcer, gastritis, splenic
injury, abscess, reflux, dissecting aortic
aneurysm, thoracic causes, pyelonephritis,
nephrolithiasis, hiatal hernia (strangulated
paraesophageal hernia), Boerhaave’s
syndrome, Mallory-Weiss tear, splenic
artery aneurysm, colon disease
AAA
Most AAAs are discovered incidentally or on screening examination.
Patients may present with symptoms related to aneurysm expansion or leakage, including back or abdominal pain. Occasionally, patients may have symptoms related to aneurysm-related thrombosis, especially in the lower extremities. Patients with a ruptured AAA are often hypotensive, and a pulsatile mass may be palpated in some patients. The lack of a pulsatile mass, however, is not reliable in excluding the diagnosis, especially in obese patients.
AAAs can be adequately evaluated either by ultrasound or by CT angiography. CT angiography is generally indicated for hemodynamically stable patients with suspected rupture, as the CT can provide additional information about aortic anatomy that will assist in intervention.
All patients with AAAs should have aggressive treatment of hypertension, hyperlipidemia, and especially tobacco dependence, as associated cardiovascular disease is very common in patients with AAAs.
Surgical treatment of asymptomatic patients who have a life expectancy of >2 years is performed when the AAA has reached a diameter of 5.5 cm or is expanding at a rate of >0.5 cm in 6 months.
Acute pancreatitis
Occurs when the pancreatic enzyme trypsinogen is prematurely activated to trypsin, which in turn activates pancreatic zymogens. The resulting pancreatic autodigestion leads to an inflammatory response that causes further pancreatic damage.
Most cases of acute pancreatitis are mild (interstitial) and self-limited, but in severe cases, the inflammation may progress to a systemic inflammatory response that can lead to capillary leak syndrome, multiple organ failure, and death. Repeated episodes of acute pancreatitis may result in chronic pancreatitis and pancreatic endocrine and exocrine insufficiency.
The most common etiologies of acute pancreatitis in the United States are: Gallstones or Alcohol. Gallstones cause the majority of cases of pancreatitis. Alcohol causes about 30% of the cases. Ten to thirty percent are idiopathic. Pancreatitis also may be caused by very high serum ⚪ triglyceride levels (>500 mg/dL)[third most common], 🥛 hypercalcemia, sphincter of Oddi dysfunction, trauma, surgery, cystic fibrosis and other genetic disorders, or penetrating peptic ulcer or as a complication of endoscopic retrograde cholangiopancreatography (ERCP).
Hx: The most common symptom of acute pancreatitis is the sudden onset of severe epigastric or diffuse abdominal pain radiating to the back. The pain usually may improve when the patient sits up or leans forward.
Drug-induced pancreatitis accounts for 5% of cases:
- Diuretics (furosemide, thiazides)
- Drugs for inflammatory bowel disease (sulfasalazine, 5-ASA)
- Immunosuppressive agents (azathioprine)
- HIV-related medications (didanosine, pentamidine)
- Antibiotics (metronidazole, tetracycline)
- Valproic acid
Nausea, vomiting, and fever are common.
Px: Abdominal tenderness (diffuse or epigastric), guarding, and distension are common in acute uncomplicated pancreatitis. Diminished bowel sounds may point to an associated ileus. Several physical findings may suggest a specific etiology; for example, jaundice suggests biliary obstruction, and eruptive xanthomas suggest hypertriglyceridemia. Evaluate for hypovolemia (tachycardia, hypotension), infection, or gastrointestinal (GI) bleeding. Large pseudocysts may be palpable and painful. The Grey-Turner or Cullen sign (painless ecchymoses in the flank or periumbilical region, respectively) suggests retroperitoneal bleeding.
Dx: Diagnosis of acute pancreatitis requires at least two of the triad of clinical symptoms, elevated serum amylase or lipase, and typical findings on imaging.
Serum lipase is more sensitive and specific than amylase and stays elevated up to 14 days after an episode of acute pancreatitis. Measuring serum lipase alone is sufficient to confirm the diagnosis of acute pancreatitis in the appropriate clinical setting. However, other conditions may also cause elevation of serum lipase, such as: Intestinal ischemia or obstruction, Duodenal ulcer, Ketoacidosis, Celiac disease, Macrolipasemia, Head trauma, intracranial mass, Kidney failure, and Heparin.
Imaging of the pancreas in acute pancreatitis is NOT indicated in all patients but should be considered in those with moderate or severe pancreatitis or persistent fever and in those who do not improve clinically within 48 to 72 hours to confirm the diagnosis, exclude other intraabdominal processes, grade the severity of pancreatitis, and diagnose local complications (pancreatic necrosis, pseudocyst, abscess).
A right upper-quadrant ultrasound 🔊 is advised for all patients with suspected gallstone pancreatitis as it provides the most accurate information regarding the presence of gallstones. If the ultrasound is nondiagnostic and there is high clinical suspicion for common bile duct disease, endoscopic retrograde cholangiopancreatography (ERCP) may be performed to better visualize the biliary tree.
CT may show enlargement or irregular contour of the gland, peripancreatic inflammation, and fluid collections. Pancreatic necrosis is identified by areas of nonenhancement on a contrast CT; Prominent peripancreatic fluid and fat-stranding
ERCP is indicated only if there is evidence of biliary obstruction (jaundice, common bile duct dilatation, or elevated liver enzymes) in a patient with cholangitis (right upper quadrant pain, fever, jaundice) or in a patient with biliary pancreatitis who is not improving clinically and whose liver enzymes are rising. Stone extraction with biliary sphincterotomy improves mortality, decreases the risk of cholangitis and biliary sepsis, and may prevent further attacks of acute biliary pancreatitis. Surgical debridement or percutaneous drainage is indicated for infected pancreatic necrosis. Cholecystectomy is indicated in patients with biliary pancreatitis to prevent recurrence.
Third spacing of fluid and hemoconcentration, identified by increased BUN, increased creatinine, and sometimes increased hematocrit, may predict morbidity and mortality because they reflect severity of capillary leak. Organ failure is defined by the presence of shock (systolic blood pressure <90 mm Hg), respiratory insufficiency (arterial PO2 <55 mm Hg), acute kidney injury (serum creatinine >2 mg/dL), or GI bleeding (>500 mL/24 h). Most patients with multiple organ system involvement have pancreatic necrosis involving 30% to 50% of the pancreas, often with infection; these patients have a very high mortality rate.
Tx: Mild acute pancreatitis is usually self-limited and is treated with bowel rest, intravenous hydration, antiemetics, and opioid analgesics.
NPO: Oral intake is withheld until there is clear clinical improvement
Nasojejunal enteral feeding in patients who are NOT improving within 72 to 96 hours.
Nasogastric suction only in patients with refractory vomiting caused by ileus.
Cx: Pancreatitis may cause significant systemic complications, mediated primarily by the effect of tissue damage and the release of cytokines and inflammatory mediators. These include hypocalcemia, hyperglycemia, acute kidney injury, disseminated intravascular coagulation, and acute respiratory distress syndrome.
Pancreatic pseudocysts are the most common complication of acute pancreatitis and may present several weeks after an episode of acute pancreatitis. A pseudocyst is a collection of pancreatic fluid with a fibrous, nonepithelialized lining. Tx: Pseudocysts are usually asymptomatic and usually resolve spontaneously. Suspect a persistent pseudocyst if pain, anorexia, or weight loss persists for several weeks. Symptomatic pseudocysts require drainage (percutaneous, endoscopic, or surgical). Pancreatic abscess (infected pseudocyst) presents with worsening abdominal pain, fever, and leukocytosis. Treatment includes antibiotics and drainage.
The best predictors of higher morbidity and mortality in patients with acute pancreatitis are those associated with hemoconcentration because it serves as a marker of capillary leak. Patients with severe disease tend to have elevated levels of blood urea nitrogen, serum creatinine, and occasionally hematocrit (all markers of hemoconcentration). Of these factors, the blood urea nitrogen level appears to be the most accurate for predicting severity. Other factors that predispose patients to a poor prognosis are multiple medical comorbidities, age greater than 70 years, and body mass index greater than 30.
Ranson’s criteria assess the severity and prognosis of pancreatitis. On admission, five criteria are considered.
It is a poor prognostic sign if:
Age > 55
WBC is greater than 16,000/mm3
Glucose is greater than 200 mg/dL
LDH is greater than 350 IU/L
AST is greater than 250 U/L
Six other criteria reflect the development of complications and include:
A decrease in hematocrit greater than 10 mg/dL
BUN increase greater than 5 mg/dL
Calcium less than 8 mg/dL
PaO2 less than 60 mm Hg
Base deficit greater than 4 mEq/L
Fluid sequestration greater than 6 L
These are assessed during the
first 48 hours of admission.
Perforated viscus: Very sudden onset (in AP, pain gradually increases over 30 min to 1 h). Intraperitoneal air present on radiographs.
Autoimmune Pancreatitis: Dx: IgG4
Chronic pancreatitis
Chronic pancreatitis is caused by pancreatic damage from repeated attacks of acute pancreatitis.
- At least 80% of patients with chronic pancreatitis have chronic abdominal pain, characteristically constant midepigastric pain radiating to the back and exacerbated by food.
- Destruction of exocrine pancreatic tissue may result in malabsorption, leading to steatorrhea and weight loss.
- Destruction of insulin-producing β-cells may lead to 🍭diabetes mellitus; concurrent destruction of glucagon-producing α-cells increases the risk of hypoglycemia in patients with diabetes.
In chronic pancreatitis, pancreatic calcifications can be seen on abdominal radiographs and CT scans, which may also show parenchymal atrophy or ductal dilatation in the pancreas
As the disease progresses, destruction of pancreatic islet and acinar cells leads to endocrine (ie, diabetes) and exocrine insufficiency, resulting in protein and fat malabsorption, steatorrhea, weight loss, and fat-soluble vitamin deficiencies. Fecal elastase is a noninvasive test with high sensitivity and specificity for severe pancreatic exocrine insufficiency. Elastase is a proenzyme (zymogen) produced in pancreatic acinar cells and activated by trypsin in the duodenal lumen; low levels indicate severe exocrine insufficiency. An alternate noninvasive test is serum trypsinogen, which would also be low in this setting. Treatment involves pancreatic enzyme replacement, which includes lipase to aid in fat digestion and improve steatorrhea.
Pancreatic Cancer
Risk factors
- Smoking
- Hereditary pancreatitis
- Nonhereditary chronic pancreatitis
- Obesity & lack of physical activity
Clinical presentation
- Systemic symptoms (eg, weight loss, anorexia) (>85%)
- Abdominal pain/back pain (80%)
- Jaundice (56%)
- Recent-onset atypical diabetes mellitus
- Unexplained migratory superficial thrombophlebitis
- Hepatomegaly & ascites with metastasis
Laboratory studies
- Cholestasis (↑ alkaline phosphatase & direct bilirubin)
- ↑ Cancer-associated antigen 19-9 (not as a screening test)
- Abdominal ultrasound (if jaundiced) or CT scan (if no jaundice)[body and tail tumors]
Pancreatic carcinoma causes painless obstructive jaundice with elevated alkaline phosphatase and normal transaminases.
🥃 Courvoisier’s sign - Painless jaundice and abdominal fullness
Approximately 25% of patients with pancreatic cancer are diagnosed with DM <2 years prior to discovery of the tumor. In particular, atypical DM (eg, DM presenting in a thin, older patient) should raise suspicion for pancreatic cancer, particularly when accompanied by other suggestive findings (eg, pain, weight loss). It is unclear whether DM promotes carcinogenesis or whether DM occurs as a consequence of a paraneoplastic syndrome from adrenomedullin secretion, leading to pancreatic beta cell dysfunction.
Screening for pancreatic cancer is not recommended in adults with new-onset diabetes because the incidence of DM is much greater than pancreatic cancer. However, those who have symptoms of pancreatic cancer such as gnawing, constant epigastric pain and weight loss require further evaluation with CT scan of the abdomen.
✖ Abdominal ultrasound is used in the initial evaluation of patients with painless jaundice, anorexia, or weight loss. However, it is not the preferred modality for screening patients who have abdominal pain without jaundice; it often misses smaller (potentially resectable) tumors; and it does not delineate tumor extension as well as CT does.
Cx: Migratory superficial thrombophlebitis, classically known as (Trousseau’s syndrome). Trousseau’s syndrome is a hypercoagulable disorder that usually presents with unexplained superficial venous thrombosis at unusual sites (eg, arm, chest area). The syndrome is usually diagnosed prior to (sometimes months to years before) or at the same time as an occult visceral malignancy.
Trousseau’s syndrome is usually associated with cancer involving the pancreas (most common), lung, prostate, stomach, and colon, and acute leukemias. Factors associated with higher risk of pancreatic cancer include increasing age and smoking. The tumor likely releases mucins that react with platelets to form platelet-rich microthrombi.
VIPoma
A rare tumor affecting the pancreatic cells that produce vasoactive intestinal peptide (VIP). Most affected adults are between ages 30-50. VIP binds to intestinal epithelial cells to increase fluid and electrolyte secretion in the intestinal lumen. Most patients develop VIPoma syndrome (pancreatic cholera) with watery diarrhea (can be tea colored and odorless), muscle weakness/cramps (due to hypokalemia), and hypo- or achlorhydria (due to decreased gastric acid secretion). The stool volume can be greater than 3L/day, leading to significant volume depletion. Other findings include facial flushing, lethargy, nausea, vomiting, abdominal pain, and weight loss. Patients can also have coexisting hyperparathyroidism as part of multiple endocrine neoplasia (MEN) syndrome.
Laboratory studies usually show hypokalemia due to increased intestinal potassium secretion. Other possible findings include hypercalcemia (due to increased bone resorption) and hyperglycemia (due to increased glycogenolysis). Stool studies are consistent with secretory diarrhea and show increased stool sodium and stool osmolal gap <50 mOsm/kg. A VIP level >75 pg/mL confirms VIPoma diagnosis. Abdominal imaging (cross-sectional triple-phase abdominal CT or MRI) can localize the tumor in the pancreas. Nearly 75% of VIPomas are in the pancreatic tail and 60%-80% have metastasized to the liver by the time of diagnosis. Treatment involves intravenous volume repletion, octreotide to decrease diarrhea, and possible hepatic resection in patients with metastasis to the liver.
Glucagonoma
Glucagonoma
Clinical presentation
- Weight loss
- Necrolytic migratory erythema: erythematous papules that coalesce to form large, indurated plaques with central clearing
- 🍭 Diabetes mellitus/hyperglycemia
- Gastrointestinal symptoms (eg, diarrhea, anorexia, abdominal pain)
Diagnosis
- Markedly elevated glucagon level
- Abdominal imaging (MRI or CT scan)
A pancreatic neuroendocrine tumor characterized by the unregulated release of glucagon. Manifestations reflect the effects of glucagon, which increases amino acid oxidation and has catabolic actions.
Glucagonoma is often diagnosed late in the disease course due to nonspecific early features; necrolytic migratory erythema (NME) is the presenting feature in ~70% of patients. NME, likely due to amino acid deficiency, is characterized by painful/pruritic papules that coalesce to form large, indurated plaques with scaling and central clearing on the face, groin, and extremities. The excess glucagon also causes hyperglycemia/diabetes mellitus, although this is usually mild and rarely requires insulin.
Other common features include weight loss (catabolic action of glucagon), diarrhea (secretion of glucagon and other molecules [eg, secretin]), venous thromboembolism, and neuropsychiatric symptoms (eg, depression, psychosis).
Laboratory evaluation typically shows normocytic, normochromic anemia, which may be due to anemia of chronic disease or a direct effect of glucagon on erythropoiesis. A markedly elevated serum glucagon level (>500 pg/mL) confirms the diagnosis. Although glucagon is increased in other conditions (eg, hypoglycemia, Cushing syndrome, pancreatitis), the elevations are typically mild to moderate. Abdominal imaging (CT scan or MRI) can localize the tumor and evaluate for metastases.
Diabetic ketoacidosis
Blood glucose always elevated; anion gap always present
Dysphagia
Dysphagia (difficulty swallowing) is categorized as either oropharyngeal (difficulty initiating a swallow, with coughing/choking after eating) or esophageal (sensation of food stuck in the esophagus). Esophageal dysphagia to both solids and liquids indicates a motility disorder, with intermittent (eg, esophageal spasm) or progressive (eg, achalasia) symptoms depending on the underlying condition. Esophageal dysphagia to solids generally reflects mechanical obstruction; symptoms can also be progressive (eg, from solids to liquids), which suggests a developing stricture or cancer, or intermittent.
Hiatal Hernia
Hiatal hernias occur when intraabdominal organs protrude into the thoracic cavity. Most (>90%) hiatal hernias are sliding hernias, which occur when the gastroesophageal junction and proximal stomach slide into the chest. Sliding hernias are usually asymptomatic or result in reflux symptoms (eg, heartburn).
In contrast, PEHs occur when the gastric fundus migrates into the thoracic cavity; larger defects can result in the subsequent herniation of the surrounding stomach and intraabdominal organs (eg, bowel, spleen). This results in compression of the stomach and surrounding organs (eg, esophagus, lungs), leading to more severe symptoms. Common manifestations include nausea and vomiting, postprandial fullness, dysphagia, and epigastric and/or chest pain. As the stomach advances into the thoracic cavity, there is risk of respiratory compromise and gastric volvulus.
The presence of a retrocardiac air-fluid level (due to the stomach bubble within the thoracic cavity) suggests a PEH, although it may also be seen in sliding hernias. The diagnosis is confirmed with barium swallow or upper endoscopy. Whereas symptomatic sliding hernias are generally managed with medical treatment of reflux symptoms, PEHs often require surgical repair.
Oropharyngeal dysphagia
Presents as difficulty initiating swallowing associated with coughing, choking, aspiration, or nasal regurgitation. Typically, patients are evaluated initially with videofluoroscopic modified barium swallow to evaluate swallowing mechanics, degree of dysfunction, and severity of aspiration.
Medication-induced esophagitis
Drug
Antibiotics
- Tetracyclines
Anti-inflammatory agents
- Aspirin & many nonsteroidal anti-inflammatory drugs
Bisphosphonates
- Alendronate, risedronate
Others
- Potassium chloride, iron
Pill esophagitis is due to a direct effect of certain medications on esophageal mucosa. Mucosal injury in pill esophagitis can be due to acid effect (eg, tetracyclines), osmotic tissue injury (eg, potassium chloride), or disruption of normal gastroesophageal protection (eg, nonsteroidal anti-inflammatory drugs). Patients usually do not have prior esophageal disease, although pill esophagitis can be worse in those with concurrent gastroesophageal reflux.
Typical symptoms of pill esophagitis include sudden-onset odynophagia and retrosternal pain that can sometimes cause difficulty swallowing. It is most common in the mid-esophagus due to compression by the aortic arch or an enlarged left atrium. The diagnosis is usually made clinically but can be confirmed on endoscopy, which shows discrete ulcers with relatively normal-appearing surrounding mucosa.
Tx: Treatment includes primarily stopping the offending medication to prevent future injury.
Eosinophilic esophagitis (EoE)
Pathogenesis
- Chronic, immune-mediated esophageal inflammation
Clinical features
- Dysphagia
- Chest/epigastric pain
- Reflux/vomiting
- Food impaction
- Associated atopy
Diagnosis
- Endoscopy & esophageal biopsy (≥15 eosinophils per high-power field)
Treatment
- Dietary modification
- ± Topical glucocorticoids
Most commonly affects younger men (age 20-30) and is associated with other atopic conditions (eg, asthma, eczema), classically presents with intermittent solid food dysphagia (often associated with eating meat) due to extensive eosinophilic infiltration of the mucosa. Other common manifestations include symptoms of refractory gastroesophageal reflux and chest/upper abdominal pain.
Symptoms are due to esophageal inflammation triggered by food allergens, and patients frequently have eczema or other allergic conditions (eg, asthma, rhinitis). Presentation typically includes dysphagia (ie, difficulty swallowing), mid-chest and epigastric pain, vomiting, and food impaction. Food refusal or a preference for soft foods is common in children. These symptoms can lead to weight loss.
If not recognized early, EoE can progress to fibrosis, leading to esophageal strictures that result in progressive dysphagia and food impaction.
The endoscopic appearance of EoE includes furrowing; small, whitish exudates; and multiple stacked, ringlike esophageal indentations (trachealization of the esophagus). The diagnosis is confirmed with esophageal biopsy demonstrating ≥15 eosinophils per high-power field. Management includes dietary therapy (eg, allergen avoidance, elimination diet), proton pump inhibitors, and topical glucocorticoids(eg, fluticasone, budesonide).
Esophageal (peptic) stricture
Chronic gastroesophageal reflux disease (GERD) predisposes to Barrett’s esophagus (intestinal metaplasia of the lower esophagus) and esophageal strictures. Both conditions are consequences of the body’s reparative response to chronic gastric acid exposure and can occur simultaneously. Benign strictures affect 5%–15% of patients with GERD. Other causes of peptic strictures include radiation, systemic sclerosis, and caustic ingestions.
Strictures typically cause slowly progressive dysphagia to solid foods without anorexia or weight loss. As they progress, they can actually block reflux, leading to improvement of heartburn symptoms. Strictures tend to appear as symmetric, circumferential narrowing on barium swallow. Nonetheless, in any case of stricture in the setting of Barrett’s esophagus, biopsy is necessary to rule out adenocarcinoma. This is usually accomplished via endoscopy which may be diagnostic and therapeutic (dilation is performed if no malignancy is detected).
Esophageal dysphagia
Presents with a sensation of food getting stuck in the esophagus (not throat) a few seconds after a swallow but does not cause difficulty initiating swallowing.
Dx: Esophageal motility studies (manometry) and upper gastrointestinal endoscopy are typically used for evaluating.
“Schotsky’s ring” reflux
Tx: Baclofen, diltiezam, nitroglycerin, nifedipine.
Nissen fundoplication, myotomy
Achalasia
This is a motor disorder of the esophagus
Hx: Dysphagia for liquids AND solids; also may be associated with chest pain. Heartburn or chest pain in achalasia is not caused by reflux but by fermentation of retained esophageal contents or esophageal muscle spasm. Patients with achalasia often regurgitate undigested food.
Dx: Manometry shows elevated pressure and poor relaxation of the lower esophageal sphincter. In classic achalasia the contractions of the esophagus are weak, although a variant called vigorous achalasia is associated with large-amplitude prolonged contractions.
Tx: Medications (nitrates, calcium channel blockers, botox injections into the LES) or physical procedures (balloon dilatation or surgical myotomy) that decrease LES pressure are the
recommended treatments.
Pseudoachalasia
Primary achalasia (ie, loss of peristalsis in the distal esophagus with lack of lower esophageal sphincter relaxation)
Pseudoachalasia due to esophageal cancer. Several clues point to pseudoachalasia (eg, narrowing of distal esophagus not due to denervation) caused by malignancy.
Dx: Endoscopic evaluation can differentiate between achalasia and pseudoachalasia. In achalasia, this evaluation usually shows normal-appearing esophageal mucosa and a dilated esophagus with possible residual material; in addition, it is generally possible to easily pass the endoscope through the lower esophageal sphincter (unlike in malignancy).
Diffuse esophageal spasm
Dysphagia for liquids and solids; also may be associated with chest pain; may be coincident with GERD
Esophageal perforation
Etiology
- Instrumentation (eg, endoscopy, TEE), trauma
- Effort rupture (Boerhaave syndrome)
- Esophagitis (infectious/pills/caustic)
Clinical presentation
- Chest/back &/or epigastric pain, systemic signs (eg, fever)
- Crepitus, Hamman sign (crunching sound on auscultation)
- Pleural effusion with atypical (eg, 🔰green) fluid
Diagnosis
- Chest x-ray or CT scan: widened mediastinum, pneumomediastinum, pneumothorax, pleural effusion
- CT scan: esophageal wall thickening, mediastinal fluid collection
- Esophagography with 💦water-soluble contrast: leak from perforation
Management
- NPO, IV antibiotics & proton pump inhibitors
- Emergency surgical consultation
Esophageal perforation is most often due to instrumentation; endoscopy, particularly when performed with additional interventions (eg, biopsy, cauterization, stricture dilation), is a common cause. Patients may develop severe chest pain (and/or back pain due to the esophagus’s posterior anatomical location) and systemic findings (eg, fever) within hours of the procedure. A minority have crepitus (subcutaneous emphysema) or crunching heard on auscultation (Hamman sign). Chest x-ray may reveal findings consistent with air/fluid leakage into the mediastinum (eg, pneumomediastinum, widened mediastinum) or thorax (eg, pneumothorax, pleural effusion).
Visualization of contrast leaking from the esophagus into surrounding tissues confirms the diagnosis, by either esophagography or CT scan using water-soluble contrast. Barium contrast is more sensitive but can incite a granulomatous inflammatory response; it is used when water-soluble contrast esophagography is inconclusive. Esophageal perforation is a life-threatening condition. Therefore, management includes emergent surgical consultation, in addition to intravenous antibiotics and proton pump inhibitors. Surgical debridement and repair remain the mainstay of treatment, although select healthy patients (eg, limited leak, minimal symptoms, no signs of sepsis) may receive a trial of medical management.
Infectious Esophagitis
Dysphagia or odynophagia; often in immunocompromised patients with candidal, CMV, or HSV esophagitis
Gastroparesis
Gastrointestinal neuropathy, often manifesting as gastroparesis, is another cause of frequent hospitalization in patients with advanced 🍭 diabetes. Gastroparesis should be suspected in a diabetic patient who has erratic glucose control with nonspecific gastrointestinal complaints and no other identifiable cause.
Delayed gastric emptying (gastroparesis) is a common cause of recurrent vomiting, nausea, early satiety, and weight loss in poorly controlled diabetics.
Dx: The best diagnostic test is a scintigraphic gastric emptying study, which will show delay in gastric emptying.
Tx: Treatment includes withdrawal of aggravating drugs such as opiates and anticholinergics, good diabetes control, and drug therapy with metoclopramide or erythromycin.
Functional dyspepsia
Up to 60% of epigastric pain; Chronic or recurrent discomfort centered around the upper abdomen.
Common causes of dyspepsia include nonsteroidal anti-inflammatory drugs, gastric or esophageal cancer, functional dyspepsia, gastroesophageal reflux disease (GERD), and symptomatic infection (eg, peptic ulcer disease [PUD]) with Helicobacter pylori (a urease-producing organism).
Hx: According to the Rome III (dyspepsia) criteria, functional dyspepsia includes one or more of the following: (1) bothersome postprandial fullness, (2) early satiety, (3) epigastric burning, and (4) epigastric pain with:
Dx: lack of structural disease on upper endoscopy, and those who do have abnormalities are found to have esophagitis. Therefore, predominant heartburn or regurgitation symptoms should be categorized as GERD rather than dyspepsia.
To establish the diagnosis, these criteria should be met for 3 months, with symptom onset at least 6 months prior to diagnosis.
Upper endoscopy is recommended in patietns with alarm features (onset after age 50 years; anemia; dysphagia; odynophagia; vomiting; weight loss; family history of upper gastrointestinal malignancy; personal history of peptic ulcer disease, gastric surgery, or gastrointestinal malignancy; and abdominal mass or lymphadenopathy on examination).
Tx: Empiric therapy with a proton pump inhibitor (PPI) is the most cost-effective management strategy.
Esophageal cancer
Barrett’s Esophagus
Hx: Dysphagia for solids (initially) and liquids (later), weight loss; often in patients with long-standing GERD; usually incurable by the time it presents clinically
Alarm symptoms present including onset after age 50 years, brief history of symptoms, weight loss, nocturnal symptoms, family history of colon cancer, rectal bleeding, and recent antibiotic use.
Patients with Barrett’s Esophagus have more severe esophageal acid reflux than those with nonerosive reflux disease. BE is a premalignant condition; patients with BE have an estimated 30- to 50-fold increased risk of developing esophageal adenocarcinoma compared with those without BE and an annual incidence of esophageal adenocarcinoma of 0.5%. Approximately 10% of patients with chronic GERD symptoms have BE on upper endoscopy. Overall survival in patients with BE is comparable to that of age- and sex-matched populations. Adenocarcinoma accounts for less than 10% of the total mortality rate in patients with BE.
Gastroesophageal reflux disease (GERD)
2%–29% of epigastric pain
Hx: Burining chest pain, worse by recumbency, caffiene, or alcohol. Atypical: hoarseness, coughing, sore throat, stridor and nocturnal asthma. Can also mimic ischemic chest pain.
Dx: The presence of heartburn, regurgitation, or both is sufficient to presumptively diagnose GERD
PPI + lifestyle x 6 weeks; EGD; 24-hour pH-impedance monitor; manometry.
Esophageal pH monitoring identifies the reflux of acid, and impedance monitoring detects reflux of other gastric contents in a small percentage of patients who have symptoms related to non-acid reflux.
Tx: After cardiac causes have been excluded by comprehensive cardiac examination, an 8- to 10-week trial of proton pump inhibitor therapy is reasonable before further testing in patients with noncardiac chest pain who do not have ❗alarm symptoms (dysphagia, odynophagia, weight loss, or gastrointestinal bleeding),
- Omeprazole (Prilosec) 20 mg QD
- Ranitidine (Zantac)
If metaplasia use high dose;
dysplasia do local ablation.
Gastric Cancer
Mid-epigastric abdominal pain, nausea/vomiting, weight loss, and microcytic anemia (likely iron deficiency). Risk is greatest in those from Eastern Asia (eg, China), Eastern Europe, and the Andean portion of South America due to diets rich in salt-preserved food and nitroso compounds, which promote gastric injury and carcinogenesis. Helicobacter pylori infection, pernicious anemia, and smoking also increase risk.
Most cases present late in the disease course when tumors have grown large enough to cause progressive epigastric abdominal pain, weight loss due to early satiety, and dysphagia or nausea/vomiting due to proximal stomach obstruction. Because friable tumor vessels often ooze blood into the gastric lumen, many patients develop iron deficiency anemia without overt signs of gastrointestinal bleeding (“slow bleed”). Metastases to the liver can also cause hepafmalttomegaly, elevated alkaline phosphatase/transaminases, and signs of liver failure (eg, hypoalbuminemia).
Dx: Workup generally begins with esophagogastroduodenoscopy to visualize the stomach and to biopsy suspicious lesions. Staging imaging (eg, CT abdomen) is then usually required to evaluate for metastatic disease.
Inferior myocardial infarction
Chest or midepigastric pain, diaphoresis, shortness of breath; elevated cardiac enzymes; acutely abnormal electrocardiogram
Differential Diagnosis of Acute Abdominal Pain: RUQ
<strong>Adult-onset jaundice:</strong>
Unconjugated hyperbilirubinemia:
<strong>Viral hepatitis </strong>accounts for up to 75% of jaundice in patients younger than 30, but only accounts for 5% of jaundice in patients older than 60 years.
<strong>Extrahepatic obstruction</strong> (gall stones, strictures, and most importantly pancreatic cancer) accounts for more than 60% of jaundice in patients older than 60 years.
<strong>Congestive heart failure </strong>accounts for around 10% of jaundice in patients older than 60,
<strong>Metastatic disease</strong> accouns for around 13%. of jaundice in patients older than 60,
Hemolytic anemia
<strong>Dx: </strong>When obstruction is suspected, ultrasound or CT scan is the appropriate initial test. If dilated bile ducts are seen, then ERCP or PTC should be done.
<strong>Childhood Jaundice</strong>
If associated with <strong><u>unconjugated </u>hyperbilirubinemia</strong> ddx includes:
<strong>Hemolytic diseases</strong> (G6PD deficiency and spherocytosis),
<strong>Gilbert disease</strong> and<strong> Crigler-Najjar syndrome.</strong>
If associated with <strong><u>conjugated </u>hyperbilirubinemia: </strong>
<strong>Viral hepatitis</strong> is the most common cause.
Less common causes include <strong>Wilson disease</strong> and milder forms of <strong>galactosemia</strong>.
Acute cholangitis
Pneumonia
Acute viral hepatitis
Acute alcoholic hepatitis
Gonococcal perihepatitis (Fitz-Hugh–Curtis syndrome)
Cholecystitis
Others: PUD, perforated
ulcer, pancreatitis, liver tumors, gastritis,
hepatic abscess, choledocholithiasis,
pyelonephritis, nephrolithiasis,
appendicitis (especially during
pregnancy); thoracic causes (e.g.,
pleurisy/pneumonia), PE, pericarditis,
MI (especially inferior MI)
Acute cholangitis
Hx: Charcot triad (RUQ pain, fever, jaundice) or Reynold pentad (Charcot triad plus shock and mental status changes).
Dx: A bilirubin >4 mg/dL. AST and ALT may be >1000 U/L; ALT usually > AST; serum alkaline phosphatase elevation is common.
Biliary stasis predisposes to AC, and the most common causes are due to bile duct obstruction from gallstones, malignancy, or stenosis. In the setting of stasis, the bile-blood barrier can be disrupted, allowing bacteria and toxins from the hepatobiliary system to translocate into the blood stream. Tx: Supportive care, broad-spectrum antibiotics, and biliary drainage, preferably by endoscopic retrograde cholangiopancreatography with sphincterotomy, are the mainstays of treatment. Other options for biliary decompression include percutaneous transhepatic cholangiography and open surgical decompression.
Acute Cholecystitis
Choledocholithiasis, Acalculous cholecystitis, Asymptomatic Gallstones
Hx: Epigastric and RUQ pain with Murphy sign; pain that radiates to right shoulder (scapula);
Dx:
Bilirubin <4 mg/dL unless complicated by choledocholithiasis; AST and ALT levels may be minimally elevated; Leukocytosis.
RUQ Ultrasound: Pericholecystic fluid and a thickened gallbladder wall; a sonographic Murphy sign (maximal tenderness directly over the visualized gallbladder) further supports the diagnosis.
Less sensitive for choledocholithiasis or for complications (abscess, perforation, and pancreatitis); shows thickened gallbladder and pericholecystic fluid.
If ultrasonography is nondiagnostic, cholescintigraphy (eg, hepatobiliary iminodiacetic acid (HIDA scan) is indicated. Nonvisualization of the gallbladder suggests cholecystitis.
ERCP is the 🥇gold standard for diagnosis and treatment of choledocholithiasis,
If bile duct stones are suspected, magnetic resonance cholangiography (MRCP) is preferred because it is more sensitive than ultrasonography and, unlike endoscopic retrograde cholangiopancreatography (ERCP), is noninvasive.
MRCP: CBD stones. Less sensitive for stones in gallbladder, malignancy.
Asymptomatic Gallstones
An estimated 60% to 80% of gallstones are asymptomatic. Over a 20-year period, 50% of patients remain asymptomatic, 30% develop biliary colic, and 20% develop more significant complications. Tx: Observation is recommended for adult patients with asymptomatic gallstones. The possible exceptions to this recommendation are groups at higher risk for gallbladder carcinoma, such as patients with a calcified (porcelain) gallbladder, certain American Indian populations, and patients with gallstones larger than 3 cm.
Tx: Symptoms often subside within a few days with volume resuscitation, antibiotics, and pain medications. However, early cholecystectomy (within 72 hours⏲) reduces disease duration, duration of hospitalization, and mortality when compared to delayed cholecystectomy (>7 days after hospitalization). Laparoscopic cholecystectomy is the surgical procedure of choice in patients without contraindications. Early cholecystectomy is also advised for patients with other complications of gallstones, such as gallstone pancreatitis.
Acalculous cholecystitis is an acute inflammation of the gallbladder in the absence of gallstones. Acalculous cholecystitis is most often seen in hospitalized patients who are critically ill. Common predisposing conditions include recent surgery (particularly cardiopulmonary, aortic, or abdominal), severe trauma, extensive burns, sepsis or shock, prolonged fasting or total parenteral nutrition, or critical illness requiring mechanical intubation. These conditions likely cause gallbladder stasis or ischemia with local inflammation that can lead to gallbladder distension, necrosis, and secondary bacterial infection.
Cx: Porcelain gallbladder is a term used to describe the calcium-laden gallbladder wall with bluish color and brittle consistency often associated with chronic cholecystitis. The pathogenesis of the condition remains unclear, but it is thought that calcium salts are deposited intramurally due to the natural progression of chronic inflammation or chronic irritation from gallstones. Plain x-rays can show a rimlike calcification in the area of the gallbladder, and CT scan typically reveals a calcified rim in the gallbladder wall with a central bile-filled dark area. Porcelain gallbladder has been associated with increased risk for gallbladder adenocarcinoma (2%-5% in some studies).
Emphysematous cholecystitis (EC) is characterized by fever, right upper quadrant (RUQ) pain, and gas in the gallbladder wall or surrounding tissue. Unlike uncomplicated acute cholecystitis, EC is a surgical emergency and warrants immediate intervention. In addition to emergency cholecystectomy, management involves broad-spectrum antibiotics (eg, piperacillin-tazobactam, ertapenem) and bile culture. EC occurs when gas-forming organisms such as Clostridium infect damaged or ischemic tissue in the gallbladder wall, with bacterial exotoxins resulting in hemolysis, tissue necrosis, and septic shock; if untreated, EC progresses to gangrenous cholecystitis and gallbladder perforation in most patients. Risk factors include relative immunosuppression (eg, age >50, diabetes mellitus) and vascular disease (eg, compromised cystic artery blood supply, atherosclerosis). In addition to pain and guarding, crepitus in the RUQ may occasionally be present. Typical laboratory findings include leukocytosis with left shift and small elevations in aminotransferases. With clostridial infection, a mild to moderate unconjugated hyperbilirubinemia can occur secondary to hemolysis. Imaging may demonstrate pneumobilia (air within the hepatobiliary system), air-fluid levels in the gallbladder, and gas within the gallbladder wall or surrounding tissue. Unlike other forms of acute cholecystitis, ultrasound is less sensitive due to the modality’s poor visualization of air-filled structures, and extensive gas in the gallbladder wall may be falsely interpreted as being due to bowel loops. CT imaging is preferred due to the improved ability to delineate air-filled structures.
Alcoholic liver disease
Common cause of chronic hepatitis and cirrhosis.
Hx: History of excessive alcohol consumption, low-grade fever, jaundice, a tender enlarged liver.
Dx: AST/ALT ratio >2. Improvement with alcohol cessation.
Tx: The goals of therapy for cirrhosis are to slow the progression of the underlying liver disease, prevent further injury to the liver, prevent and treat complications (esophageal varices, ascites, hepatic encephalopathy, hepatocellular carcinoma), and evaluate the patient for liver transplantation.
Protein-calorie malnutrition and hypermetabolism are common in patients with cirrhosis, and nutritional assessment is important. Patients with alcoholism should receive folate and thiamine supplementation, and patients with ascites should have dietary sodium restriction (<2 g/day).
While patients with mild to moderate alcoholic hepatitis have a reasonably good prognosis with alcohol abstinence and supportive care, those with severe hepatitis have a high short-term mortality rate and may benefit from treatment, which may include glucocorticoids and pentoxifylline in addition to supportive measures.
The Maddrey discriminant function (DF) score, which helps to identify patients whose short-term survival is improved by glucocorticoid therapy, is calculated as follows:
DF = 4.6 (Prothrombin time [s] − Control prothrombin time [s]) + Serum bilirubin (mg/dL)
Patients with a DF score >32 have a >50% short-term (30-day) mortality risk. Such patients are candidates for therapy with prednisone. Pentoxifylline may be used as an alternative for patients with contraindications or early renal failure.
The Lille score is another method to determine if patients with alcoholic hepatitis are responding to glucocorticoid therapy. It combines six variables: age, renal insufficiency (Cr >1.3 or creatinine clearance <40 mL/minute), albumin, prothrombin time, bilirubin, and evolution of bilirubin at day 7 (bilirubin at day 7 – bilirubin at day 0). A score >0.45 suggests that a patient is not responding to glucocorticoid therapy.
Cx: Sialadenosisis commonly found in patients with advanced liver disease (eg, alcoholic and nonalcoholic cirrhosis). It is also seen in patients with altered dietary patterns or malnutrition (eg, diabetes, bulimia).
Sialadenosis is a benign, noninflammatory swelling of the salivary glands. It is associated with abnormal autonomic innervation of the glands, with accumulation of secretory granules in acinar cells.
Autoimmune hepatitis
Typically young women (90%) with fatigue and jaundice.
Dx: Aminotransferase elevations; hypergammaglobulinemia and other autoimmune diseases may be present. Look for specific autoantibodies (ANA, ASMA); AST:ALT ratio less than 2.
Biliary crystals (microlithiasis, sludge)
Typical biliary pain and no gallstones on imaging studies. If necessary, diagnosis made by aspiration of gallbladder bile from the duodenum or directly from the gallbladder during ERCP and microscopic examination. May cause pain, cholecystitis, or pancreatitis. Treated with cholecystectomy.
Biliary dyskinesia (gallblader dysmotility)[statis]
Hx: Abdominal pain with normal ultrasonographic imaging. Typical biliary pain, no gallstones on imaging studies. Symptoms similar to those of biliary colic.
The presence of proteins and fatty acids in the duodenum acts as a stimulus for release of cholecystokinin (CCK), which in turn stimulates the contraction of the gallbladder. In patients on total parenteral nutrition or prolonged fasting, the normal stimulus for CCK release and gallbladder contraction is absent. This leads to biliary stasis and promotes the formation of bile sludge and gallstones. Small-bowel (ileal) resection also contributed to the formation of gallstones. Decreased enterohepatic circulation of bile acids results in altered hepatic bile composition, which becomes supersaturated with cholesterol and promotes gallstone formation.
Dx: CCK-induced gallbladder ejection fraction <35%–40% on cholescintigraphy. Symptoms usually relieved with cholecystectomy. Sphincter of Oddi manometry may be required to diagnose sphincter of Oddi dysfunction.
Drug-induced chronic hepatitis
Exposure history most commonly alcohol but may be medications (methotrexate, amiodarone, high-dose vitamin A) or chemicals (hydrocarbons). Long-term TPN can lead to cirrhosis.
Acetaminophen toxicity results from overproduction of the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI), which leads to hepatic necrosis. NAPQI is normally safely detoxified through glucuronidation in the liver, but this pathway becomes overwhelmed in overdose. Chronic alcohol use is thought to potentiate acetaminophen hepatotoxicity by depleting glutathione levels and impairing the glucuronidation process. On the other hand, N-acetylcysteine increases glutathione levels and binds to NAPQI, so it is an effective antidote for acetaminophen overdose when given early.
Doses of greater than 3 g/d are needed to cause hepatotoxicity (typically results in serum AST and ALT values greater than 5000 U/L).
Tx: Drug discontinuation.
Echinococcal cyst
Can cause anaphylaxis with eventual shock. However, an echinococcal cyst usually appears on abdominal CT as a cystic liver lesion (sometimes with calcifications) without gallbladder involvement. It would be unlikely in a patient who has never traveled outside the United States.
Scores 💯🎼
Child-Pugh classification: The Child-Pugh classification has been used to assess the risk of non-shunt operations in patients with cirrhosis. Patients with a score of 5 or 6 have Child-Pugh class A cirrhosis (well-compensated cirrhosis), those with a score of 7 to 9 have Child-Pugh class B cirrhosis (significant functional compromise), and those with a score of 10 to 15 have Child-Pugh class C cirrhosis (decompensated cirrhosis).
MELD score: Another model to predict prognosis in patients with cirrhosis is the MELD score. It is based upon bilirubin levels, creatinine, INR, and the etiology of cirrhosis. The MELD score has been adopted for use in prioritizing patients awaiting liver transplantation and has an expanding role in predicting outcomes in patients with liver disease in the non-transplantation setting.
FIB-4 index: The FIB-4 index combines biochemical values (platelet count, ALT, and AST) and age. It had good predictive accuracy for advanced fibrosis in at least two studies involving patients with chronic HCV. FIB-4 values have also been associated with the risk of developing hepatocellular carcinoma (HCC) among patients who consume alcohol.
Fulminant Liver Failure
<strong>Liver “synthetic” function test (clotting factors, cholesterol, and proteins)</strong>
- Serum albumin and PT/INR
+bilirubin
<strong>Metabolic </strong>(metabolism of drugs and corticosteroids, including detoxification)
<strong>Excretory </strong>(bile excretion)
Tests of hepatic <strong>function </strong>are more suggestive of<strong> chronic disease </strong>as opposed to acute injury.
“Acute liver Failure” is defined as severe acute liver injury without underlying liver disease and is characterized by elevated aminotransferases (often >1,000 U/L), hepatic encephalopathy, and synthetic liver dysfunction (defined as prolonged prothrombin time [PT] with INR >1.5). Tx: Approximately only half of patients with ALF will survive without liver transplantation.
Dx: Typically presents with evidence of liver dysfunction in addition to the disturbance of bilirubin metabolism. Findings often include an increase in coagulation time (as measured by the international normalized ratio) due to a decrease in liver production of coagulation factors and a low serum albumin level due to decreased liver albumin production.
Hyperestrinism is due to impaired hepatic metabolism of circulating estrogens, a process that begins in the cytochrome P450 system. Circulating estrogens affect vascular wall dilation.
Spider angioma consists of a central, dilated arteriole surrounded by smaller radiating vessels.
Palmar erythema is a result of increased normal speckling of the palm due to increased vasodilation, especially at the thenar and hypothenar eminences.
Other manifestations of hyperestrinism in patients with cirrhosis include gynecomastia, testicular atrophy, and decreased body hair in males.
Caput medusae arise from the dilation of superficial veins on the abdominal wall due to portal hypertension (PH). PH results from increased resistance to portal flow at the sinusoids and leads to increased pressure at the portosystemic collateral veins in the anterior abdomen, rectum, and distal esophagus.
Hepatic encephalopathy (HE) may also be present because of the inability of the liver to clear toxic metabolic by-products from the blood.
❗Precipitating factors for HE include azotemia, acute liver decompensation, use of sedatives or opioids, GI hemorrhage, hypokalemia, constipation, infection, a high-protein diet, and recent placement of a portosystemic shunt (TIPS).
🍌Hypokalemia can exacerbate HE as the resultant intracellular acidosis (excreted intracellular potassium replaced by hydrogen ions to maintain electroneutrality) causes increased NH3 production (glutamine conversion) in renal tubular cells. Tx: repletion
Metabolic alkalosis (elevated bicarbonate) can also exacerbate HE as it promotes conversion of ammonium (NH4+), which cannot enter the CNS, to NH3, which can enter the CNS
Serum binding proteins for thyroid hormones (eg, thyroxine-binding globulin, transthyretin, albumin, lipoproteins). Cirrhosis leads to decreased synthesis of these proteins, which lowers the total triiodothyronine (T3) and thyroxine (T4) in circulation; however, free T3 and T4 levels are unchanged, and TSH will be normal, reflecting a euthyroid status.
Tx: Lactulose; If not recognized and treated, encephalopathy progresses from subtle findings, such as reversal of the sleep-wake cycle or mild mental status changes, to irritability, confusion, slurred speech, and ultimately coma. There can be multiple inciting causes of encephalopathy in patients with cirrhosis, including dehydration, infection (especially spontaneous bacterial peritonitis), dietary indiscretions, gastrointestinal bleeding, and medications.
Tx: All patients with cirrhosis undergo screening upper endoscopy to detect large esophageal varices. Small varices are usually less than 5 mm in diameter; large varices are > 5 mm.
- Grade 1 – Small, straight esophageal varices.
- Grade 2 – Enlarged, tortuous esophageal varices occupying less than one third of the lumen.
- Grade 3 – Large, coil-shaped esophageal varices occupying more than one third of the lumen.
Tx:
Initial treatment of suspected variceal bleeding includes volume resuscitation, through 2 to 3 large-bore peripheral intravenous lines. Prophylactic antibiotics (eg, ceftriaxone) should be given to cirrhotic patients with gastrointestinal bleeding to decrease infectious complications, recurrent bleeding, and mortality.
Somatostatin analogues (eg, octreotide) inhibit the release of vasodilator hormones, which leads indirectly to splanchnic vasoconstriction and decreased portal flow.
Urgent endoscopy (within 12 hours) can diagnose and treat (eg, endoscopic band ligation, sclerotherapy) active bleeding.
Uncontrollable bleeding require temporary balloon tamponade (eg, Sengstaken-Blakemore, Minnesota, Linton-Nachlas tubes) as a short-term measure until more definitive therapy, including transjugular intrahepatic portosystemic shunt (TIPS) or shunt surgery. Patients without further bleeding after endoscopy can be monitored and receive secondary prophylaxis (beta blocker) with repeat endoscopic band ligation 1-2 weeks later.
When large varices are present, the next step in management is use of nonselective β-blocker therapy or endoscopic variceal band ligation as primary prophylaxis to prevent variceal hemorrhage.
Patients with contraindications to β-blocker therapy, such as asthma or resting bradycardia, can be offered endoscopic ligation.
Hepatorenal Syndrome Arterial vasodilatation in the splanchnic circulation, which is triggered by portal hypertension, appears to play a central role in the hemodynamic changes and the decline in renal function in cirrhosis.
Type 1: 2x increase in serum creatinine >2.5 mg/dL during a period of less than 2 weeks. Urine output less than 400 to 500 per day is common.
Type 2: impairement is less servere than above. Patients typically have ascities resistant to diuretics.
Tx: Midodrine, Octreotide
Hepatopulmonary syndrome results from intrapulmonary vascular dilations. Patients frequently have evidence of platypnea (increased dyspnea while upright) or orthodeoxia (oxygen desaturation while upright).
Tx: Liver Transplant
Cirrhosis caused by hepatitis C is the most common cause for liver transplantation in the United States.
Absolute contraindications:
Portal vein thrombosis, severe medical illness, malignancy, hepatobiliary sepsis, or lack of patient understanding.
Relative contraindications:
Active alcoholism (<6 mo), HIV or hepatitis B surface antigen positivity, extensive previous abdominal surgery, and a lack of a personal support system.
Hepatocellular Carcinoma
HCC usually arises in the setting of chronic liver inflammation due to alcohol abuse, environmental toxins (eg, aflatoxin, betel nut chewing), or viral hepatitis (eg, hepatitis B virus [HBV], hepatitis C virus [HCV]). Incidence is greatest in Asia (eg, Vietnam), Africa, and the Middle East due to high rates of underlying HBV/HCV infection. In these regions, viral transmission often occurs via the maternal-to-child route, leading lifelong viral hepatitis in the newborn (and increased risk of cirrhosis/HCC later in life).
Screening for HCC every 6 to 12 months is recommended for patients with cirrhosis of any cause and for patients with chronic hepatitis B who are considered at high risk (active inflammation and age >40 years in men and >50 years in women; a family history of HCC; specific ethnic groups [Asians, African/North American blacks]).
Hx: Patients with HCC often develop systemic (eg, weight loss, fatigue), abdominal (eg, right upper quadrant pain, early satiety), or metastatic (eg, bone pain) manifestations. Liver function tests may be normal or elevated; alkaline phosphatase is occasionally dramatically elevated due to osteoblastic bone metastases. Significant elevation in alpha-fetoprotein raises strong suspicion for HCC but is present only in ~50% of cases.
Dx: HCC derives its blood supply by neovascularization, whereby the tumor develops a new blood supply fed through small branches of the hepatic artery. It is this characteristic vascular supply that helps identify potential cancers on contrast-enhanced imaging, such as triple-phase CT and gadolinium-enhanced magnetic resonance imaging (MRI). Current guidelines recommend the use of ultrasonography to screen for HCC, followed by CT or MRI to better define any abnormalities suggestive of HCC.
Alpha-fetoprotein (AFP), a glycoprotein produced by the fetal liver and yolk sac, is elevated in 50% of cases; therefore, AFP can serve as an important diagnostic clue (when elevated) but cannot be used to rule out the diagnosis. Triple phase arterial contrast CT scan of the abdomen is diagnostic in most cases.
The presence of elevated alpha-fetoprotein (AFP), a glycoprotein produced by the fetal liver and yolk sac, raises strong suspicion for primary testicular (yolk sac) or liver (hepatocellular carcinoma [HCC]) cancer
Hepatic encephalopathy
Precipitating factors
- Drugs (eg, sedatives, narcotics)
- Hypovolemia (eg, diarrhea)
- Electrolyte changes (eg, hypokalemia)
- ↑ Nitrogen load (eg, GI bleeding)
- Infection (eg, pneumonia, UTI, SBP)
- Portosystemic shunting (eg, TIPS)
Clinical presentation
- Sleep pattern changes
- Altered mental status
- Ataxia
- Asterixis
Treatment
- Correct precipitating causes (eg, fluids, antibiotics)
- ↓ Blood ammonia concentration (eg, lactulose, rifaximin)
HE refers to impaired central nervous system (CNS) function in patients with cirrhosis and is due in part to the neurotoxicity from ammonia (NH3) in the setting of impaired liver function.
Hypokalemia, which can exacerbate HE as the resultant intracellular acidosis (excreted intracellular potassium replaced by hydrogen ions to maintain electroneutrality) causes increased NH3 production (glutamine conversion) in renal tubular cells
Metabolic alkalosis (elevated bicarbonate), which can also exacerbate HE as it promotes conversion of ammonium (NH4+), which cannot enter the CNS, to NH3, which can enter the CNS
As a result, patients with HE and hypokalemia require prompt potassium repletion in addition to intravascular volume repletion. Disaccharides (eg, lactulose, lactitol) are also administered to lower NH3 levels.
Focal nodular hyperplasia (FNH)
A benign regenerative liver nodule common in women age 20-50.
Most cases of FNH are asymptomatic and are discovered during abdominal imaging for other conditions. Lesions tend to be ⚪ well-circumscribed, solitary, and <5 cm in size; they characteristically have a central, stellate scar 🌟, which surrounds a large congenital arterial anomaly that sends arterial branches to the periphery. Imaging with triphasic, helical CT scan (which evaluates the mass during different phases of vascular contrast) generally reveals a hyperdense lesion (ie, filled with contrast during hepatic arterial phase) and a central scar.
Because FNH does not generally grow over time, undergo malignant transformation, or rupture, treatment is rarely required. Oral contraception is not believed to worsen FNH; therefore, contraception usually can be continued (in contrast to hepatic adenoma).
Hepatic Adenoma
Hepatic adenomas generally arise in young women who have been on prolonged estrogen-based oral contraception.
Epidemiology
- Benign epithelial liver tumor
- Primarily young women on oral contraception
Manifestations
- Often asymptomatic (incidentally found)
- Episodic right upper quadrant pain
Imaging
- Solitary, solid lesion in right lobe of liver
- Multiple lesions occasionally occur
Treatment
- Asymptomatic & <5 cm – 🛑 stop oral contraception
- Symptomatic or >5 cm – 🔪 surgical resection
Complications
- Malignant transformation (~10%)
- Rupture & hemorrhagic shock
Although considered benign and often discovered incidentally on imaging for other conditions, hepatic adenoma can cause life-threatening complications such as malignant transformation and rupture.
Cx: Rupture should be suspected in those with sudden-onset, severe right upper quadrant pain who have signs of hemorrhagic shock; low-grade fever and mild leukocytosis also sometimes occur due to peritoneal irritation from blood in the abdominal cavity. Ultrasound generally reveals a single, solid liver lesion (usually in the right hepatic lobe) and free fluid (blood) in the abdomen. Urgent circulatory support and surgical intervention are required to prevent death.
[NAFLD] Nonalcoholic fatty liver disease
(Inflammation and fibrosis associated with NAFLD are referred to as nonalcoholic steatohepatitis (<strong>NASH</strong>).
The condition is characterized by triglyceride accumulation in the hepatocytes (steatosis).
The underlying pathophysiology is closely linked to insulin resistance and hence to obesity, diabetes, hyperlipidemia and the metabolic syndrome. Most cases are discovered
incidentally because of elevated transaminases. Patients may have nonspecific right upper quadrant discomfort and hepatomegaly.
Spectrum of liver disease ranges from steatosis to steatohepatitis to cirrhosis. Perhaps most common cause of chronic hepatitis in United States.
NAFL is associated with mAcrovesicular accumulation of fat in the liver. NAFLD can be due to increased transport of free fatty acids (FFA) from adipose tissue to the liver, decreased oxidation of FFA in the liver, or decreased clearance of FFA from the liver (due to decreased VLDL production). [Microvesicular fat is seen in the acute life-threatening conditions of acute fatty liver of pregnancy and Reye syndrome.]
It is frequently related to peripheral insulin resistance leading to increased peripheral lipolysis, triglyceride synthesis, and hepatic uptake of fatty acids. Hepatic FFA increases oxidative stress and production of proinflammatory cytokines (eg, tumor necrosis factor-alpha).
Hx: Usually results from insulin resistance and the metabolic syndrome (obesity, diabetes mellitus, dyslipidemia, and hypertension).
Dx: If hepatocellular necrosis is present, the condition is termed nonalcoholic steatohepatitis (NASH). NASH may be inferred in patients who have the metabolic syndrome and elevated serum aminotransferase levels in the absence of other causes of liver disease. Liver ultrasonography shows fatty infiltration. Liver biopsy confirms NASH and identifies the degree of hepatic inflammation and fibrosis. This condition is histologically similar to alcoholic hepatitis, and increasing evidence suggests that it too is a precirrhotic condition.
Tx: The mainstay of treatment of NAFLD and NASH is weight loss and management of comorbidities.
Hemochromatosis
Skin
- Hyperpigmentation (bronze diabetes)
Musculoskeletal
- Arthralgia, arthropathy & chondrocalcinosis
Gastrointestinal
- Elevated hepatic enzymes with hepatomegaly (early), cirrhosis (later) & increased risk of hepatocellular carcinoma
Endocrine
- Diabetes mellitus, secondary hypogonadism & hypothyroidism
Cardiac
- Restrictive or dilated cardiomyopathy & conduction abnormalities
Infections
- Increased susceptibility to Listeria, Vibrio vulnificus & Yersinia enterocolitica
Hemochromatosis is an autosomal recessive condition that causes increased intestinal absorption of iron and excessive total body iron stores. The cause is a defect in the HFE or related gene. It affects Caucasians most frequently at a rate of about 1 in 250 persons.
The increased total body iron leads to deposits in various organs (eg, liver, pancreas), resulting in multisystem organ damage. Disease progression typically requires decades of increased iron deposition. Consequently, patients tend to present in their 30s to 50s, with women presenting later due to therapeutic iron loss through menstruation.
Most patients with HH are diagnosed early in the disease due to elevated liver enzymes on routine laboratory studies. However, continued iron deposition can cause hepatic fibrosis and cirrhosis, skin pigmentation (sun-exposed areas, scars, genitalia), diabetes mellitus (“bronze diabetes”), arthropathy, and hypogonadism (diminished libido, erectile dysfunction [ED]). Diabetes occurs secondary to direct damage to the pancreas by iron deposition.
The initial evaluation of HH commonly shows elevated iron studies. Initial screening involves transferrin saturation (iron/total iron binding capacity) and ferritin levels. A transferrin saturation > 45% or a ferritin > 150 would be consistent with the diagnosis and would suggest the need for referral and genetic testing.
Patients with HH have an approximate 20-fold increased risk for hepatocellular cancer (HCC), accounting for 45% of deaths in HH patients.
Primary sclerosing cholangitis
Progressive bile duct inflammation, destruction, and ultimately fibrosis of both the intrahepatic and extrahepatic bile ducts, which leads to cirrhosis.
Hx: Typically men in their late 30s who are asymptomatic (incidental finding of elevated alkaline phosphatase), particularly in patients with established ulcerative colitis. The most common symptoms of PSC are pruritus and fatigue; as the disease progresses, most patients develop jaundice.
Diagnosis usually by endoscopic cholangiography.
Dx: When patients with PSC are found to have acute worsening of liver chemistry test results (markedly elevated ALP level and mildly elevated aminotransferase levels), acute worsening of symptoms, or a new dominant stricture noted on cholangiography, the possibility of cholangiocarcinoma should be considered. The diagnosis of PSC depends on detecting multifocal strictures alternating with normal, dilated segment of the bile ducts leading to a “beaded” pattern on cholangiographic imaging.
Ulcerative colitis is an independent risk factor for development of colorectal cancer, and patients with both ulcerative colitis and PSC may represent a distinct phenotype of disease with a particularly high rate of colorectal cancer.
Primary biliary cholangitis (Pka Primary biliary cirrhosis)
Pathogenesis
- Autoimmune destruction of intrahepatic bile ducts
Clinical features
- Affects middle-aged women
- Insidious onset of fatigue & pruritus
- Progressive jaundice, hepatomegaly, cirrhosis
- Cutaneous xanthomas & xanthelasmas
Laboratory findings
- Cholestatic pattern of liver injury (↑↑ alkaline phosphatase, ↑ aminotransferases)
- Antimitochondrial antibody
- Severe hypercholesterolemia
Treatment
- Ursodeoxycholic acid (delays progression)
- Liver transplantation for advanced disease
Complications
- Malabsorption, fat-soluble vitamin deficiencies
- Metabolic bone disease (osteoporosis, osteomalacia)
- Hepatocellular carcinoma
PBC is a chronic liver disease characterized by autoimmune destruction of the intrahepatic bile ducts with resulting cholestasis.
A chronic, progressive liver disease characterized by cholestasis with autoimmune destruction of intrahepatic bile ducts.
Hx: Typically women in their 50s who are often asymptomatic at diagnosis (incidental finding of elevated 🔰alkaline phosphatase). It presents as chronic cholestasis with fatigue, pruritus without rash, hyperpigmentation, and sometimes xanthomas. As the disease progresses, jaundice, hepatomegaly, steatorrhea, and portal hypertension may develop. Additional complications can include severe hyperlipidemia (with xanthelasma) and metabolic bone disease. PBC is often associated with other autoimmune disorders (eg, autoimmune thyroid disease).
Dx: Ultrasound to look for intrahepatic cholestasis. Most patients have antimitochondrial antibodies and elevated serum IgM, γ-glutamyl transferase, and ALP levels; aminotransferase levels also may be elevated.
Ultrasonography should be used to exclude extrahepatic bile duct obstruction. PBC frequently is associated with other autoimmune disorders, such as hypothyroidism, Sjögren syndrome, sicca syndrome, and systemic sclerosis.
Tx: Ursodeoxycholic acid (UDCA) is used in a number of cholestatic disorders and is the drug of choice in PBC. UDCA is a hydrophilic bile acid that decreases biliary injury by the more hydrophobic endogenous bile acids. It also increases biliary secretion and may have additional anti-inflammatory and immunomodulatory effects. UDCA delays histologic progression in PBC and may improve symptoms and possibly survival. It should be initiated as soon as the diagnosis is made, even in asymptomatic patients. Treatment is less effective in advanced disease, and many patients will go on to require liver transplantation.
♒ Ascites Fluid Characteristics
Color
- Bloody: Trauma, malignancy, TB (rarely)
- Milky: Chylous, pancreatic
- Turbid: Possible infection
- Straw color: Likely more benign causes
Neutrophils
- <250/mm3: No peritonitis
- ≥250/mm3: Peritonitis (secondary or spontaneous bacterial)
Total protein
- ≥2.5 g/dL (high-protein ascites)
- CHF, constrictive pericarditis, peritoneal carcinomatosis, TB, Budd-Chiari syndrome, fungal (eg, coccidioidomycosis)
- <2.5 g/dL (low-protein ascites)
- Cirrhosis, nephrotic syndrome
SAAG
- ≥1.1 g/dL (indicates portal hypertension)
- Cardiac ascites, cirrhosis, Budd-Chiari syndrome
- <1.1 g/dL (absence of portal hypertension)
- TB, peritoneal carcinomatosis, pancreatic ascites, nephrotic syndrome
Dx:
🧪 Cell count and differential
>250/µL neutrophils diagnostic for ❗ Spontaneous Bacterial Peritonitis (SBP) with infection most commonly from enteric gram negative rods. Treatment should be initiated immediately to cover gram negative organisms. Standard antibiotic therapy is a 🌼fluoroquinolone or third-generation cephalosporin for 7 to 10 days.
Spontaneous bacterial peritonitis (SBP) is the occurrence of bacterial infection in preexisting ascitic fluid without bowel wall perforation. It is almost always caused by a single species (isolation of multiple species would suggest a bowel wall perforation). The addition of albumin to antibiotic therapy has been shown to improve survival.
🧪 Albumin level (The serum albumin should be drawn at the same time of the procedure to calculate the SAAG)
Serum Ascities Albumin Gradient (SAAG) is important in determining the etiology of the underlying ascites. It is calculated by subtracting the ascitic fluid ⚪albumin concentration from the serum ⚪albumin level (3.2 mg/dL – 1.0 mg/dL = 2.2 mg/dL).
SAAG ≥ 1.1 g/dL 97% accurate for diagnosing ascites caused by portal hypertension and points to underlying🐄 liver (cirhosis, alk hep, hepatic metastasis, budd-chiari, protal vein thrombosis) or 🧡 cardiac disease (heart failure, constricticve pericarditis).
SAAG < 1.1 (Peritoneal 💜TB, peritoneal 🦀carcinomatosis, serositis, 🧽 Pancreatitis, ⚪nephrotic syndrome)
🧪 Total protein
>2.5 g/dL (high-protein ascities)[CHF, constrictive pericarditis, TB, budd chiari, fungal)
<2.5 g/dL identify patients at high risk for SBP (cirrhosis, nephrotic syndrome)
🧪 Gram stain and Culture (in blood culture bottles)
Used to identify causative organisms of SBP
Glucose
Low glucose suggests peritonitis caused by infection, bowel perforation, or tumor
Lactate dehydrogenase (LDH)
An ascitic-serum LDH ratio >1 suggest peritonitis caused by infection, bowel perforation, or tumor
Acid-fast bacilli smear and culture
Smear has very low sensitivity for tuberculous (TB) peritonitis; culture sensitivity approximately 50%
Triglycerides 🔰 Chylous ascites
Amylase
Elevated in ascites caused by 🧽 pancreatitis
Cytology
Used when 🦀malignant ascites is suspected; sensitivity, 58%–75%
Spontaneous bacterial peritonitis
Clinical presentation
- Temperature >37.8 C (100 F)
- Abdominal pain/tenderness
- Altered mental status (abnormal connect-the-numbers test)
- Hypotension, hypothermia, paralytic ileus with severe infection
Diagnosis from ascitic fluid
- PMNs >250/mm3
- Positive culture, often gram-negative organisms (eg, Escherichia coli, Klebsiella)
- Protein <1 g/dL
- SAAG >1.1 g/dL
Treatment
- Empiric antibiotics - third-generation cephalosporins (eg, cefotaxime)
- Fluoroquinolones for SBP prophylaxis
Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection without an obvious intraabdominal surgical etiology. SBP is most likely due to either intestinal bacterial translocation directly into the ascitic fluid or hematogenous spread to the liver and ascitic fluid (due to other bacterial infections).
Patients with cirrhosis are often relatively hypothermic, and any temperature ≥37.8 C (100 F) warrants investigation. Other manifestations of SBP may include diffuse abdominal discomfort/tenderness and/or mental status changes. The Reitan trail test, a timed connect-the-numbers test similar to children’s connect-the-dots pictures, is excellent for use in detecting subtle mental status changes sometimes present in patients with cirrhosis and SBP. Hypotension, hypothermia, or paralytic ileus (dilated loops of bowel on x-ray) indicate severe SBP. As the vast majority of cases of SBP are associated with cirrhosis, the serum-ascites albumin gradient (SAAG) is usually ≥1.1 g/dL (a SAAG <1.1 g/dL makes SBP unlikely). Ascitic fluid with a polymorphonuclear leukocyte (PMN) count ≥250/mm3 and positive peritoneal fluid culture confirm the diagnosis.
Viral hepatitis
At least five distinct causes. Determined by serologic testing for hepatitis A, B, C, D, and E and confirmation of viral replication of hepatitis B and C. RIBA for HCV infection may also be used for confirmation.
Hepatitis A
Since the introduction of routine hepatitis A vaccination in the United States, infection rates have fallen significantly, but disease transmission remains a risk for a number of groups, including international travelers, men who have sex with men, illicit drug users, and those with household or sexual contact with infected persons. Transmission occurs most frequently via the fecal-oral route, although sexual and blood-borne transmission can also occur.
Hepatitis A typically is associated with an abrupt onset of constitutional symptoms, such as fatigue, anorexia, malaise, nausea, and vomiting. Low-grade fever and right upper quadrant pain often are present as well.
Dx:
Markedly elevated transaminases, positive hepatitis A IgM antibody [Ab], negative hepatitis A IgG Ab.
Confirm the diagnosis with serologic testing, specifically IgM antibody to HAV. In most patients, IgM antibody is detectable by the time a person is symptomatic and becomes undetectable by 6 months. The IgG antibody indicates prior infection and immunity; there is no chronic state of hepatitis A.
Serum AST and ALT > 500 U/L, often greater than 1000 U/L; ALT > AST
Postexposure prophylaxis with hepatitis A vaccine or hepatitis A immune globulin should be considered in a number of groups, including:
Close personal contacts (eg, sexual contacts, household contacts) of hepatitis A-infected patients
Child care center contacts (eg, staff and children) where staff, children, or household contacts of attendees have been infected
Food preparation workers whose coworkers have been infected
Prophylaxis should be given within 2 weeks of exposure; in general, younger patients (age <40) should receive hepatitis A vaccine, whereas older patients (age >41) should receive hepatitis A immune globulin.
Hepatitis B
Inactive carrier state there would be no evidence of active viral replication with circulating viral DNA)
Chronic HBV infection:
Immune-tolerant is identified by the presence of a circulating viral level in the absence of markers of liver inflammation. This pattern typically occurs in patients born in hepatitis B–endemic areas such as Southeast Asia or Africa in whom HBV was likely acquired perinatally. As long as patients maintain normal serum aminotransferase levels, they are at low risk for progression of liver disease.
A “window period” exists when HBsAg levels have fallen but antibody to HBsAg (anti-HBs) has not yet become detectable; diagnosis is then based on the presence of antibody to hepatitis B core antigen (anti-HBc [IgM]).
The first serologic marker to appear in the serum with acute hepatitis B is HBsAg, which appears usually 4-8 weeks after infection. IgM anti-HBc appears shortly thereafter, which is around the time clinical symptoms occur and patients develop elevations in hepatic aminotransferase levels (often >25 times the normal limit).
Test patients with evidence of chronic liver disease for chronic hepatitis B. Also test patients with glomerulonephritis, polyarteritis nodosa, or cryoglobulinemia because these are extrahepatic manifestations of chronic hepatitis B.
Tx: Patients with chronic hepatitis B and a circulating viral level may show evidence of liver inflammation, evidenced by persistently elevated serum aminotransferase levels indicating active hepatitis. In these patients, liver biopsy should be considered and treatment should be initiated if significant inflammation or progressive liver injury is seen.
Hepatitis C
Hepatitis C infection is often progressive and may result in cirrhosis and hepatocellular carcinoma. Untreated, about 15% of patients with hepatitis C will eventually develop cirrhosis.
Hx: Usually manifests as chronic liver disease because the acute infection is usually asymptomatic.
Dx:
Because treatments are available to eradicate HCV infection, screening is recommended for high-risk groups such as patients born between 1945 and 1965 (who represent ~75% of patients with HCV) and those with a history of injection drug use, HIV infection, or blood product transfusion prior to 1992.
Test patients with chronic liver disease for anti-HCV antibody. Because the virus may spontaneously clear in up to half of affected patients, diagnosis of chronic infection is a 2-step process that requires both a positive serologic test for the HCV antibody and a confirmatory molecular test for the presence of circulating HCV RNA.
Patients with positive antibodies and NEGATIVE HCV RNA generally have either:
- Resolved infection: A minority of patients (15%-40%) are able to spontaneously clear HCV infection; these individuals are not infectious, have no sequelae of disease, and do not require treatment.
- False-positive HCV antibody test
Once the diagnosis has been confirmed with dual testing, patients should undergo further evaluation to identify the HCV genotype and the extent of liver fibrosis.
Tx: Previous treatments were based on pegylated interferon and ribavirin, the introduction of protease inhibitors effective against HCV (eg, boceprevir, simeprevir, telepravir) and direct-acting antiviral agents (eg, ledipasvir-sofosbuvir) has markedly changed HCV therapy. Antiviral therapy for HCV infection is associated with significant morbidity; therefore, which patients are candidates for antiviral therapy should be carefully considered. Females, patients under age 40, patients with minimal or no cirrhosis, and those infected with genotypes 2 and 3 are more likely to respond to treatment.
All patients with chronic hepatitis C should receive 💉vaccination against hepatitis A and B, which can cause fulminant hepatic failure in patients with preexisting hepatitis C.
Cx: Extrahepatic complications of hepatitis C, including:
Mixed cryoglobulinemia syndrome (eg, palpable purpura, arthralgias, glomerulonephritis, low complement levels), lichen planus, and porphyria cutanea tarda (PCT).
Ischemic hepatopathy
Hallmark of ischemic hepatopathy is a rapid and significant increase in the transaminaseswith modest accompanying elevations in total bilirubin and alkaline phosphatase. AST and ALT levels peak at 25 to 250 times the upper limit of normal and can reach >10,000 U/L. This reflects diffuse liver injury due to hypotension; as a result of the liver’s dual blood supply, diffuse injury is more common than focal infarction. In patients who survive the underlying cause of their hypotension (eg, septic shock, heart failure), liver enzymes typically return to normal within 1-2 weeks.
Cryoglobulinemia
Type I
- Lymphoproliferative or hematologic (eg, multiple myeloma)
- Asymptomatic
- Hyperviscosity (eg, blurry vision), thrombosis (eg, Raynaud phenomenon)
- Skin: Livedo reticularis, purpura
- Complement levels: Normal
Mixed (types II & III)
- Chronic HCV, HIV
- Systemic lupus erythematosus
- Systemic: Fatigue, arthralgias
- Renal: Glomerulonephritis, HTN
- Pulmonary: Dyspnea, pleurisy
- Skin: Palpable purpura, LCV
- Low C4
Mixed cryoglobulinemia syndrome (MCS) is caused by immune complex deposition in small- to medium-size blood vessels, leading to endothelial injury and end-organ damage. It commonly presents with fatigue; nonblanching, palpable purpura; arthralgias; renal disease (eg, hematuria, proteinuria, glomerulonephritis); and peripheral neuropathies. Renal involvement is variable, but the most common manifestation is hypertension. Liver involvement (eg, elevated transaminases) is common. Patients rarely may have central nervous system or pulmonary involvement.
MCS is most commonly associated with chronic inflammatory conditions such as hepatitis C virus (HCV) infection and systemic lupus erythematosus. Consequently, every patient suspected of having MCS should be tested for HCV, hepatitis B virus, and HIV. HCV-associated MCS immune complexes are formed from HCV, anti-HCV IgG, IgM anti-IgG antibodies (rheumatoid factor), and complement.
Diagnosis of MCS can be confirmed serologically (serum cryoglobulins, low complement levels) or with a skin/renal biopsy.
Treatment involves addressing the underlying disease and can also include plasmapheresis and immunosuppression (eg, glucocorticoids, rituximab) for patients with rapidly progressive or life-threatening courses.
Porphyria cutanea tarda (PCT)
Porphyria cutanea tarda (PCT) presents with fragile, photosensitive skin that develops vesicles and bullae with trauma or sun exposure (eg, dorsa of the hands). Healed lesions typically scar and can form both hypo- and hyperpigmented areas. HCV is strongly associated with PCT, and all patients with PCT should be screened. Dx: Diagnosis of PCT is supported by increased plasma and urine porphyrins. Tx: involves either serial phlebotomy or hydroxychloroquine along with management of underlying causes (eg, HCV).
Shock Liver (Ischemic hepatopathy)
Diffuse liver injury due to hypotension; as a result of the liver’s dual blood supply, diffuse injury is more common than focal infarction.
Dx: Rapid and significant increase in the transaminases with modest accompanying elevations in total bilirubin and alkaline phosphatase. AST and ALT levels peak at 25 to 250 times the upper limit of normal and can reach >10,000 U/L.
In patients who survive the underlying cause of their hypotension (eg, septic shock, heart failure), liver enzymes typically return to normal within 1-2 weeks.
↗↗↗↗ LUQ Differential Diagnosis of Acute Abdominal Pain:
Peptic ulcer Disease
Peptic Ulcer Disease
The two most common causes of peptic ulcer disease are infection with H. pylori and the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
Hx: Pain or distress centered in the upper abdomen; 😊relieved by food 🍗 or antacids. The classic symptoms of duodenal ulcer occur in the absence of a food buffer and can include epigastric pain 2-5 hours after meals, on an empty stomach, or at night.
Dx: The initial diagnosis of H. pylori infection may be done by endoscopic studies (either histologic examination of biopsy tissue OR rapid urease testing) OR non-endoscopic studies (serum antibody tests, the urea breath test, or stool examination for H. pylori antigens).
Ulcerative lesions visualized with endoscopy; 7%–25% of epigastric pain.
Tx: Triple therapy consisting of a PPI (antisecretory therapy), amoxicillin, and clarithromycin (antibiotic eradication) is the most commonly used initial treatment.
Fu: Patients should undergo fecal Helicobacter pylori antigen testing to verify eradication of the infection. Urea breath test and fecal antigen testing are practical and noninvasive methods for detecting any residual H. pylori infection.
Cx: Perforating Peptic Ulcer
Postprandial abdominal pain, weight loss, abdominal bruit (chronic presentation); pain out of proportion to tenderness on palpation
Perforated viscus
A perforated viscus typically presents with severe abdominal pain, fever, tachycardia, and signs of peritonitis (eg, rigidity, reduced bowel sounds, rebound tenderness).
Full-thickness erosion of a peptic ulcer through the stomach or duodenal wall releases both air and caustic (ie, pH ~1-2) gastric secretions/contents into the peritoneal cavity. This quickly results in chemical peritonitis (eg, marked abdominal tenderness with guarding) and an early systemic inflammatory response (eg, fever, tachycardia) that can progress to sepsis and shock if left untreated.
Patients with free perforation causing gross spillage of gastrointestinal contents (vs microperforation with little to no spillage) can often note the precise time the perforation occurred. Sudden, severe pain is typical.
The diagnosis of gastrointestinal perforation is confirmed with upright x-ray of the chest and abdomen, which typically shows free intraperitoneal air under the diaphragm (pneumoperitoneum).
Demonstration of intraperitoneal free air (eg, on upright x-ray) confirms the diagnosis and should prompt immediate surgical consultation, since many patients require surgical intervention and delay increases mortality (which is up to 30%, even with treatment).
Acute Mesenteric ischemia (Ischemic Colitis)
Presentation
- Rapid onset of periumbilical pain (often severe)
- Pain out of proportion to examination findings
- Hematochezia (late complication)
Risk factors
- Atherosclerosis (acute or chronic)
- Embolic source (thrombus, vegetations)
- Hypercoagulable disorders
Cardiac embolic events in the setting of atrial fibrillation, valvular disease, or cardiovascular aneurysms; Acute thrombosis due to peripheral arterial disease or low cardiac output states
Laboratory findings
- Leukocytosis
- Elevated amylase & phosphate levels
- Metabolic acidosis (elevated lactate)
Diagnosis
- CT (preferred) or MR angiography
- Mesenteric angiography if diagnosis is unclear
Elderly patients with vascular disease. Intermittent mesenteric ischemia occurs from atherosclerotic obstruction of visceral arteries.
CMI commonly presents with crampy, postprandial epigastric pain (intestinal angina), food aversion, and weight loss.
The pathophysiology of the pain is most likely related to shunting of blood away from the small intestine to meet the increased demand of the stomach.
Classic triad: postprandial abdominal pain, weight loss, and abdominal bruit.
Px: Acute mesenteric ischemia is characterized by pain out of proportion to examination findings and metabolic acidosis.
Physical examination may show signs of malnutrition and may reveal an abdominal bruit in ~50% of patients, but can be otherwise unremarkable.
Dx: Although abdominal x-ray and CT scans may demonstrate calcified vessels, diagnosis requires better visualization of the vessels. CT angiography is the preferred choice, although Doppler ultrasonography may also be helpful.
Possible anion gap metabolic acidosis; 💀abdominal plain films may show classic thumbprinting sign (acute presentation).
Tx: Treatment involves risk reduction (eg, tobacco cessation), nutritional support, and revascularization.
Chronic 🕰 mesenteric ischemia (CMI)
CMI commonly presents with crampy, postprandial epigastric pain (intestinal angina), food aversion, and weight loss. Patients may also report nausea, early satiety, and diarrhea. The anginal pain frequently starts within the first hour of eating and slowly resolves over the next 2 hours. The pathophysiology of the pain is most likely related to shunting of blood away from the small intestine to meet the increased demand of the stomach. In patients with atherosclerosis, the celiac or the superior mesenteric arteries may be narrowed and unable to dilate appropriately to maintain adequate blood flow to the intestines.
Px: Physical examination may show signs of malnutrition and may reveal an abdominal bruit in ~50% of patients, but can be otherwise unremarkable. Although abdominal x-ray and CT scans may demonstrate calcified vessels, diagnosis requires better visualization of the vessels.
Dx: CT angiography is the preferred choice, although Doppler ultrasonography may also be helpful. Treatment involves risk reduction (eg, tobacco cessation), nutritional support, and revascularization.
Gastrinoma (Zollinger-Ellison syndrome [ZES])
ZES is usually sporadic but is found in conjunction with multiple endocrine neoplasia type 1 (MEN-1) in 20% of cases. Gastrinomas usually occur in patients age 20-50 with dyspepsia, reflux symptoms, abdominal pain, weight loss, diarrhea, or frank gastrointestinal bleeding.
Dx: Endoscopy often shows thickened gastric folds, multiple peptic ulcers, refractory ulcers despite proton pump inhibitor (PPI) use, or ulcers distal to the duodenum in the jejunum (suggesting excess gastric acid that cannot be fully neutralized in the duodenum).
Dx: Fasting serum gastrin level (off PPI therapy for 1 week) should be checked in suspected gastrinoma; a level <110 pg/mL rules it out, and a level >1000 pg/mL is diagnostic. If gastrin is elevated, gastric pH should also be measured as gastrin may also be elevated due to failure of gastric acid secretion (achlorhydria). A gastrin level of 110-1000 pg/mL is non-diagnostic and requires a follow-up secretin stimulation test. Secretin stimulates the release of gastrin by gastrinoma cells. Normal gastric G cells are inhibited by secretin; therefore, secretin administration should not cause a rise in serum gastrin concentrations in patients with other causes of hypergastrinemia.
Extranodal marginal zone B cell lymphoma
Extranodal marginal zone B cell lymphomas (low-grade B cell lymphoma of mucosa-associated lymphoid tissue [MALT]) of the stomach. It is present in 90% of patients with tumors. Chronic inflammation from H pylori infection results in stimulation of large numbers of antigen-dependent B and T cells in the gastric lamina. The chronic activation and proliferation eventually results in a monoclonal population of B cells that no longer depends on normal stimulatory pathways for growth.
As a result, all patients with MALT lymphomas should be tested for H pylori infection, and patients with a positive result who have early-stage MALT lymphoma should undergo H pylori eradication therapy (eg, quadruple therapy). The majority of patients achieve complete remission with antibiotic treatment. Patients with more advanced malignancies or with H pylori-negative tumors should be considered for radiation therapy, immunotherapy (eg, rituximab), or single-agent chemotherapy.